New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
June 4, 2014
07:19 EDTHIPP, NEO, TNXP, LOCM, XXII, FNJN, CLIR, APGILD Micro to hold a conference
LD Micro 4th Invitational Conference to be held in Los Angeles on June 4.
News For TNXP;APGI;XXII;NEO;CLIR;LOCM;HIPP;FNJN From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
July 23, 2015
07:51 EDTNEONeoGenomics lowers FY15 revenue guidance to 100M-$103M from $103M-$108M
Consensus $103.78M. NeoGenomics reiterated its expectation of a return to profitability in the second half of 2015.
07:21 EDTNEONeoGenomics reports Q2 EPS 0c, consensus (1c)
Subscribe for More Information
July 22, 2015
07:09 EDTNEONeoGenomics expands multimodality cancer profile testing
NeoGenomics expanded its comprehensive multimodality NeoTYPE tumor-type specific cancer profiling tests to include new profiles for head and neck tumors, pancreatic cancer, liver cancer, sarcoma, and for cancers of unknown primary. These new tests integrate a variety of technologies, including next generation sequencing, viral in-situ hybridization, FISH, and immunohistochemistry. A number of new tests are being added to NeoGenomics cancer diagnostic test menu.
July 20, 2015
07:07 EDTNEONeoGenomics launches germline cancer predisposition testing
Subscribe for More Information
July 16, 2015
08:36 EDTFNJNFinjan Holdings files second lawsuit against Blue Coat
Finjan Holdings (FNJN) announced that its subsidiary, Finjan, Inc. has filed a second patent infringement lawsuit against Blue Coat Systems, alleging infringement of seven Finjan patents relating to new infringing Blue Coat products and services. The Complaint, filed July 15, 2015, in the U.S. District Court for the Northern District of California, alleges that Blue Coat's new products and services infringe seven Finjan patents. In particular, Finjan is asserting infringement of U.S. Patent Nos. 6,154,844; 6,965,968; 7,418,731; 8,079,086; 8,225,408; 8,566,580; 8,677,494; four of which are being asserted against Blue Coat for the first time. Finjan is seeking a jury trial; entry of judgment of direct and indirect infringement of certain claims of each of the asserted patents by Blue Coat; preliminary and permanent injunction against Blue Coat and its officers, among others, from infringing the asserted patents; and damages to be determined by a jury. This original case against Blue Coat will be proceeding to trial on July 20, 2015, with all six patents included in Finjan's first complaint against Blue Coat. Those patents include 6,804,780; 6,154,844; 7,418,731; 6,965,968; 7,058,822 and 7,647,633. The trial in the first case is expected to last for two weeks. Finjan has filed patent infringement lawsuits against FireEye (FEYE), Proofpoint, Sophos, Symantec (SYMC), and Palo Alto Networks (PANW) relating to, collectively, more than 20 patents in the Finjan portfolio.

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use